Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy.
about
Expression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurityStudies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis)Triamcinolone acetonide prevents enhancement of hypoxia-induced neuronal and inducible nitric oxide synthases in the retinas of rats with oxygen-induced retinopathy.Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model.Disruption of the association of integrin-associated protein (IAP) with tyrosine phosphatase non-receptor type substrate-1 (SHPS)-1 inhibits pathophysiological changes in retinal endothelial function in a rat model of diabetes.Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity.Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity.VEGF-mediated STAT3 activation inhibits retinal vascularization by down-regulating local erythropoietin expression.The role of supplemental oxygen and JAK/STAT signaling in intravitreous neovascularization in a ROP rat model.Effects of triamcinolone acetonide on vessels of the posterior segment of the eye.Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP.Glucocorticoids exert direct toxicity on microvasculature: analysis of cell death mechanisms.Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity.
P2860
Q28583644-0522162E-54C6-42B6-ABFB-2B21FD2FB6F1Q33787955-17CCB151-6BEC-4749-87E2-7CEC0AF02717Q36424494-F0C5397E-F284-4DDF-9701-38A9977A89F2Q36618068-1C31624F-F8FF-4632-B7E2-8D464A9BB99CQ37049770-1A610A0B-A583-4DA6-8B5C-F91E9D3520E0Q37405102-42886623-2029-4905-A415-6C9E00B0A703Q41829449-E88F0500-6ECB-45BF-986D-4DC6D45CB864Q42044757-173F2434-3DC3-4DBA-B25A-FA984BD0E8CDQ42155684-69C924C2-EA88-422A-A615-FEEA4FCDB398Q42464404-07CB5626-16F2-4B9B-8314-242C94920C87Q42577163-48A77FF0-FD70-4C12-8AAA-C013EE764591Q42703437-D0AFF2CE-51AD-4F39-8850-7A72EC5A2919Q42942158-D6061B22-FD9D-4509-9E96-42A2F7AF8EA0
P2860
Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Triamcinolone reduces neovascu ...... of oxygen-induced retinopathy.
@ast
Triamcinolone reduces neovascu ...... of oxygen-induced retinopathy.
@en
type
label
Triamcinolone reduces neovascu ...... of oxygen-induced retinopathy.
@ast
Triamcinolone reduces neovascu ...... of oxygen-induced retinopathy.
@en
prefLabel
Triamcinolone reduces neovascu ...... of oxygen-induced retinopathy.
@ast
Triamcinolone reduces neovascu ...... of oxygen-induced retinopathy.
@en
P2093
P2860
P356
P1476
Triamcinolone reduces neovascu ...... of oxygen-induced retinopathy.
@en
P2093
David J Martiniuk
Janet R McColm
Lynda J Peterson
M Elizabeth Hartnett
Pete Geisen
Yuta Saito
P2860
P304
P356
10.1167/IOVS.06-0450
P407
P577
2006-11-01T00:00:00Z